Author:
Cappuzzo Federico,Ardizzoni Andrea,Soto-Parra Hector,Gridelli Cesare,Maione Paolo,Tiseo Marcello,Calandri Cesare,Bartolini Stefania,Santoro Armando,Crinò Lucio
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference18 articles.
1. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project;Crino;J. Clin. Oncol.,1999
2. Molecules in focus: EGF receptor;Wells;Int. J. Biochem. Cell Biol.,1999
3. Objective regressions in non-small cell lung cancer patients treated in phase I trials of ZD1839 (‘Iressa’), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR);Kris;Lung Cancer,2000
4. Antitumour effect and potentiation of cytotoxic drug activity in human cancer cells by ZD1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor;Ciardiello;Clin. Cancer Res.,2000
5. ZD1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical development;Woodburn;Proc. Am. Assoc. Cancer Res.,1997
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献